This webinar features a panel of industry experts discussing key statistical models and analysis within the therapy development market in China.
- Overview of Statistical Methods in Innovative Drug Development
- Statistical Analysis of Advanced Therapies for Rare Diseases and Case Studies
- Considerations of Innovative Statistical Methods in FDA Review
"Integrating Biostatistics in Advanced Therapy Development: Key Insights and Applications for China"
Panelists
Dr. David Ng
Vice President of Biometrics & Data Management, Novotech
Dr. Yafei Zhang
Director of Biostatistics, Novotech
Dr. Shan Xiao
Associate Director of Biostatistics, Takeda Pharmaceuticals